Understanding Resistance to Chemotherapy using Liquid Biopsies and Droplet Digital PCR

In this interview filmed at AACR 2017, hear how researchers at the Dana-Farber Cancer Institute are using Droplet Digital PCR to detect key mutations in cell-free DNA from liquid biopsies, helping improve understanding of drug resistance development as well as inform treatment decisions.